Levothyroxine but Not Selenium Increases Endothelial Progenitor Cell Counts in Patients with Hypothyroidism
Author(s) -
Roberto Negro,
Giacomo Greco
Publication year - 2016
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000445945
Subject(s) - medicine , euthyroid , levothyroxine , endocrinology , endothelial progenitor cell , placebo , diabetes mellitus , thyroid disease , thyroid , gastroenterology , progenitor cell , stem cell , alternative medicine , pathology , biology , genetics
Hypothyroidism is a common endocrine disease associated with increased oxidative stress, increased cardiovascular (CV) risk, CV events and endothelial dysfunction. Endothelial progenitor cells (EPCs) are a well-known marker of CV risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom